These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 9253404)
1. Structure of thymidylate kinase reveals the cause behind the limiting step in AZT activation. Lavie A; Vetter IR; Konrad M; Goody RS; Reinstein J; Schlichting I Nat Struct Biol; 1997 Aug; 4(8):601-4. PubMed ID: 9253404 [No Abstract] [Full Text] [Related]
2. AZT monophosphate knocks thymidylate kinase for a loop. Kenyon GL Nat Struct Biol; 1997 Aug; 4(8):595-7. PubMed ID: 9253402 [No Abstract] [Full Text] [Related]
3. Structural requirements for efficient phosphorylation of nucleotide analogs by human thymidylate kinase. Lavie A; Konrad M Mini Rev Med Chem; 2004 May; 4(4):351-9. PubMed ID: 15134538 [TBL] [Abstract][Full Text] [Related]
4. Structural basis for the efficient phosphorylation of AZT-MP (3'-azido-3'-deoxythymidine monophosphate) and dGMP by Plasmodium falciparum type I thymidylate kinase. Whittingham JL; Carrero-Lerida J; Brannigan JA; Ruiz-Perez LM; Silva AP; Fogg MJ; Wilkinson AJ; Gilbert IH; Wilson KS; González-Pacanowska D Biochem J; 2010 May; 428(3):499-509. PubMed ID: 20353400 [TBL] [Abstract][Full Text] [Related]
5. Potentiating AZT activation: structures of wild-type and mutant human thymidylate kinase suggest reasons for the mutants' improved kinetics with the HIV prodrug metabolite AZTMP. Ostermann N; Lavie A; Padiyar S; Brundiers R; Veit T; Reinstein J; Goody RS; Konrad M; Schlichting I J Mol Biol; 2000 Nov; 304(1):43-53. PubMed ID: 11071809 [TBL] [Abstract][Full Text] [Related]
6. Synthesis of carbocyclic nucleotides as potential substrates for thymidylate kinase. Ludek OR; Meier C Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):683-6. PubMed ID: 16248014 [TBL] [Abstract][Full Text] [Related]
7. The crystal structure of Mycobacterium tuberculosis thymidylate kinase in complex with 3'-azidodeoxythymidine monophosphate suggests a mechanism for competitive inhibition. Fioravanti E; Adam V; Munier-Lehmann H; Bourgeois D Biochemistry; 2005 Jan; 44(1):130-7. PubMed ID: 15628853 [TBL] [Abstract][Full Text] [Related]
8. Modifying human thymidylate kinase to potentiate azidothymidine activation. Brundiers R; Lavie A; Veit T; Reinstein J; Schlichting I; Ostermann N; Goody RS; Konrad M J Biol Chem; 1999 Dec; 274(50):35289-92. PubMed ID: 10585390 [TBL] [Abstract][Full Text] [Related]
9. Structural basis for efficient phosphorylation of 3'-azidothymidine monophosphate by Escherichia coli thymidylate kinase. Lavie A; Ostermann N; Brundiers R; Goody RS; Reinstein J; Konrad M; Schlichting I Proc Natl Acad Sci U S A; 1998 Nov; 95(24):14045-50. PubMed ID: 9826650 [TBL] [Abstract][Full Text] [Related]
10. Thymidine and zidovudine metabolism in chronically zidovudine-exposed cells in vitro. Agarwal RP; Mian AM Biochem Pharmacol; 1991 Jul; 42(4):905-11. PubMed ID: 1867645 [TBL] [Abstract][Full Text] [Related]
11. Structures of human thymidylate kinase in complex with prodrugs: implications for the structure-based design of novel compounds. Ostermann N; Segura-Peña D; Meier C; Veit T; Monnerjahn C; Konrad M; Lavie A Biochemistry; 2003 Mar; 42(9):2568-77. PubMed ID: 12614151 [TBL] [Abstract][Full Text] [Related]
12. The highly similar TMP kinases of Yersinia pestis and Escherichia coli differ markedly in their AZTMP phosphorylating activity. Chenal-Francisque V; Tourneux L; Carniel E; Christova P; Li de la Sierra I; Bârzu O; Gilles AM Eur J Biochem; 1999 Oct; 265(1):112-9. PubMed ID: 10491164 [TBL] [Abstract][Full Text] [Related]
13. Crystal structure of yeast thymidylate kinase complexed with the bisubstrate inhibitor P1-(5'-adenosyl) P5-(5'-thymidyl) pentaphosphate (TP5A) at 2.0 A resolution: implications for catalysis and AZT activation. Lavie A; Konrad M; Brundiers R; Goody RS; Schlichting I; Reinstein J Biochemistry; 1998 Mar; 37(11):3677-86. PubMed ID: 9521686 [TBL] [Abstract][Full Text] [Related]
14. Characterization of the activation pathway of phosphoramidate triester prodrugs of stavudine and zidovudine. Saboulard D; Naesens L; Cahard D; Salgado A; Pathirana R; Velazquez S; McGuigan C; De Clercq E; Balzarini J Mol Pharmacol; 1999 Oct; 56(4):693-704. PubMed ID: 10496951 [TBL] [Abstract][Full Text] [Related]
15. Novel nucleotide analogues as potential substrates for TMPK, a key enzyme in the metabolism of AZT. Müller HC; Meier C; Balzarini J; Reinstein J Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):821-3. PubMed ID: 14565287 [TBL] [Abstract][Full Text] [Related]
16. Electrochemical reduction products of azido nucleosides, including zidovudine (AZT): mechanisms and relevance to their intracellular metabolism. Kawczyński W; Czochralska B; Shugar D Acta Biochim Pol; 1993; 40(2):213-23. PubMed ID: 8212958 [TBL] [Abstract][Full Text] [Related]
17. Reduction of 3'-azido-3'-deoxythymidine (AZT) and AZT nucleotides by thiols. Kinetics and product identification. Reardon JE; Crouch RC; St John-Williams L J Biol Chem; 1994 Jun; 269(23):15999-6008. PubMed ID: 8206896 [TBL] [Abstract][Full Text] [Related]
18. Intracellular metabolism of CycloSaligenyl 3'-azido-2', 3'-dideoxythymidine monophosphate, a prodrug of 3'-azido-2', 3'-dideoxythymidine (zidovudine). Balzarini J; Naesens L; Aquaro S; Knispel T; Perno C; De Clercq E; Meier C Mol Pharmacol; 1999 Dec; 56(6):1354-61. PubMed ID: 10570065 [TBL] [Abstract][Full Text] [Related]
19. Conformation and local environment of nucleotides bound to HIV type 1 reverse transcriptase (HIV-1 RT) in the ground state. Painter GR; Andrews CW; Furman PA Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):13-29. PubMed ID: 10772700 [TBL] [Abstract][Full Text] [Related]
20. Sensitivity of HIV-1 reverse transcriptase and its mutants to inhibition by azidothymidine triphosphate. Carroll SS; Geib J; Olsen DB; Stahlhut M; Shafer JA; Kuo LC Biochemistry; 1994 Mar; 33(8):2113-20. PubMed ID: 7509634 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]